Initiates Coverage on InspireMD (NYSE:NSPR)

Equities researchers at initiated coverage on shares of InspireMD (NYSE:NSPRGet Rating) in a research note issued on Monday. The firm set a “sell” rating on the stock.

InspireMD Stock Performance

Shares of InspireMD stock opened at $1.17 on Monday. InspireMD has a fifty-two week low of $0.81 and a fifty-two week high of $3.33. The company has a market capitalization of $9.77 million, a P/E ratio of -0.52 and a beta of 0.96. The company has a fifty day moving average of $1.17 and a 200 day moving average of $1.26.

InspireMD Company Profile

(Get Rating)

InspireMD, Inc is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions.

Featured Articles

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with's FREE daily email newsletter.